Avalon GloboCare Announces up to $9.75 Million Private Placement Priced At-the-Market under Nasdaq Rules Avalon GloboCare (NASDAQ: ALBT) entered definitive agreements for a private placement to sell 6,372,550 shares (or pre-funded warrants) and associated Series A-1 and A-2 warrants at $0.51 per share.The offering is expected to close on or about February 27, 2026, raising approximately $3.25 million in gross proceeds upfront and up to an additional $6.5 million if warrants are fully exercised. Net proceeds will be used to repay certain debt and for working capital.

#ALBT Avalon GloboCare Announces up to $9.75 Million Private Placement Priced At-the-Market under Nasdaq Rules

www.stocktitan.net/news/ALBT/avalon-globo-c...

Nasdaq Tumbles Over 350 Points; US Initial Jobless Claims Increase - Antelope Enterprise Hldgs (NASDAQ:AEHL), Avalon Globocare (NASDAQ:ALBT)

Nasdaq Tumbles Over 350 Points; US Initial Jobless Claims Increase Importance Rank: 1 read more

#AEHL #ALBT #ARRY #CURX #Earnings #ELPW #EOSE #Equities #Mid-Morning #Market #Update

Origin | Interest | Match

Avalon GloboCare’s Subsidiary Accepted into AMD AI Developer Program to Advance Next-Generation Media Infrastructure Avalon GloboCare (NASDAQ: ALBT) was accepted into the AMD AI Developer Program on Feb. 26, 2026, giving its AI subsidiary AQAI access to AMD Developer Cloud credits, tools, training, and community resources.Avalon plans to use AMD Instinct accelerators and EPYC processors to speed model training, inference, and scalability for automated evidence-constrained video generation, AI-assisted drafting, compliance tooling, and workflow automation.

#ALBT Avalon GloboCare’s Subsidiary Accepted into AMD AI Developer Program to Advance Next-Generation Media Infrastructure

www.stocktitan.net/news/ALBT/avalon-globo-c...

Trade Alerts, Monday December 15, 2025 – Crystal Equity Research

Small-cap stocks gapping down in trading, Mon Dec 15th - #SMX #PCLA #ORKT #MIGI #LEXX #GOVX #GLXG #FBLG #EPSM #SNSE #MNTS #IRBT #ATOS #ALBT - More: crystalequityresearch.com/trade-alerts... - #smallcap

Myseum Completes Sale of Minority Stake in RPM Interactive for Approximately $6.5 Million in Avalon GloboCare Acquisition NEW BRUNSWICK, N.J., Dec. 15, 2025 (GLOBE NEWSWIRE) -- Myseum, Inc. (Nasdaq: MYSE) (“Myseum” or the “Company”) today announced the completion of the sale...

#MYSE Myseum Completes Sale of Minority Stake in RPM Interactive for Approximately $6.5 Million in Avalon GloboCare Acquisition
www.globenewswire.com/news-release...
#ALBT #Acquisition

Avalon GloboCare Acquires RPM Interactive, a Generative AI Software Company, in an All-Stock Transaction Company forms a new subsidiary, Avalon Quantum AI, LLC, in connection with the acquisition Acquisition expected to resolve Nasdaq minimum stockholders’ equity deficiency RPM Interactive has developed a fully automated, generative AI powered SaaS platform for creating short-form video content

#ALBT Avalon GloboCare Acquires RPM Interactive, a Generative AI Software Company, in an All-Stock Transaction

www.stocktitan.net/news/ALBT/avalon-globo-c...

Avalon GloboCare Reports Q3 2025 Progress with KetoAir™, Holistic Health Initiatives, and International Expansion Avalon GloboCare (NASDAQ: ALBT) reported Q3 2025 progress for its KetoAir™ breathalyzer, highlighting a UK commercial launch on Sept 1, 2025, presentation at the London Health Optimization Summit on Sept 13–14, 2025, and a Nevada first‑responder program started in August 2025.The four‑month Nevada POOL/PACT Holistic Health Reset enrolled 50 first responders using KetoAir™ for daily ketone monitoring; October mid‑program data showed individual metabolic improvements. KetoAir™ is FDA‑registered (Reg. No. 3026284320), measures breath acetone (BrAce), and is manufactured by Qi Diagnostics; device apps are available on Apple App Store and Google Play.

#ALBT Avalon GloboCare Reports Q3 2025 Progress with KetoAir™, Holistic Health Initiatives, and International Expansion

www.stocktitan.net/news/ALBT/avalon-globo-c...

Trade Alerts, Tuesday October 14, 2025 – Crystal Equity Research

Small-cap stocks with strong volume declines, Tue Oct 14th - #PFAI #OP #NEXM #HVII #SEED #QH #BYND #BCRX #BCAB #ALBT #SOJD #OEC #NMG - More: crystalequityresearch.com/trade-alerts... - #smallcap

FDA-Registered Ketosis Breath Analyzer: Avalon GloboCare Brings KetoAir to UK Keto Diet Market Avalon's KetoAir breathalyzer for ketogenic diet monitoring launches on KetoAir.uk. FDA-registered device measures breath acetone for real-time ketosis tracking, compatible with iOS/Android.

#ALBT Avalon GloboCare to Launch Online Sales of KetoAir Breathalyzer in the United Kingdom

www.stocktitan.net/news/ALBT/avalon-globo-c...

Most Searched, Monday July 28, 2025 – Crystal Equity Research

Most searched small-cap stocks, Mon Jul 28th - #XXII #DNN #OPEN #NVTS #PLUG #PLUG #HIVE #RERE #MCVT #SBET #ALBT #TLRY #WULF #VWAV #WRD #LIDR #IOVA #SMX #COUR #RXRX #FFAI - More: crystalequityresearch.com/most-searche...

Avalon GloboCare Targets First Responders with Revolutionary Ketosis Monitoring Device New distribution agreement brings KetoAir breathalyzer to first responders. FDA-registered device measures ketosis in real-time via breath analysis. Learn more.

#ALBT Avalon GloboCare Enters into Distribution Agreement with Saga Health for KetoAir Targeting First Responders

www.stocktitan.net/news/ALBT/avalon-globo-c...

Breakthrough CAR-T Cell Therapy Patent Secures 20-Year Protection in Hong Kong Market Novel dual-targeting CAR-T/NK cell therapy technology receives Hong Kong patent protection through 2040. Enhances cancer treatment efficacy. See breakthrough details.

#ALBT Avalon GloboCare Announces Patent Issuance for Novel CAR-T and CAR-NK Cell Technology in Hong Kong

www.stocktitan.net/news/ALBT/avalon-globo-c...

Real-Time Cannabis Breathalyzer Could Transform DUI Detection: Avalon GloboCare Partners with Qi Diagnostics New nanosensor technology aims to revolutionize cannabis impairment detection for law enforcement. Partnership targets real-time roadside testing capabilities. Learn more.

#ALBT Avalon GloboCare and Qi Diagnostics Enter into Definitive Agreement to Co-Develop Real-Time Cannabis Breathalyzer for Detecting Potential Impaired Driving

www.stocktitan.net/news/ALBT/avalon-globo-c...

Monteverde Associates Investigates Recent Mergers Affecting Shareholders of Four Companies Monteverde & Associates PC launches an investigation into mergers involving companies like ALBT and DNB, aiming to protect shareholder interests.

Monteverde Associates Investigates Recent Mergers Affecting Shareholders of Four Companies #United_States #New_York #Monteverde_Associates #DNB #ALBT

Avalon GloboCare Advances Proposed Merger with YOOV with Filing of Registration Statement Avalon GloboCare Corp. (“Avalon” or the “Company”) (NASDAQ: ALBT), a commercial-stage company dedicated to developing and delivering precision diagnostic consumer products, and YOOV Group Holding Limited (“YOOV”), a provider of highly advanced

#ALBT Avalon GloboCare Advances Proposed Merger with YOOV with Filing of Registration Statement

www.stocktitan.net/news/ALBT/avalon-globo-c...

Game-Changing Cancer Treatment Patent: Dual-Target CAR-T Tech Secures 20-Year China Protection Breakthrough bispecific CD19/CD22 CAR-T technology receives 20-year patent protection in China, expanding global immunotherapy portfolio. Full impact analysis inside.

#ALBT Avalon GloboCare Announces Issuance of Patent for Novel CAR-T and CAR-NK Cell Technology in China

www.stocktitan.net/news/ALBT/avalon-globo-c...

Avalon GloboCare and YOOV, a Leading Business AI Automation Solutions Provider, Enter into Merger Agreement Avalon GloboCare (NASDAQ: ALBT) has announced a definitive merger agreement with YOOV, a leading business AI automation solutions provider. The merged entity will operate as YOOV and trade under the ticker 'YOOV' on Nasdaq, pending approval.YOOV demonstrated strong financial performance with unaudited revenue of $45.7 million and net income of $3.4 million for calendar year 2024, compared to $28.7 million revenue and $2.4 million net loss in 2023, representing 59.1% annual revenue growth.Post-merger ownership structure will see YOOV shareholders holding approximately 97.5-97.8% of the combined company, while Avalon shareholders will retain 2.2-2.5%. The transaction is expected to close in Q3 2025, subject to stockholder approval. Phil Wong will serve as Chairman, CEO, and President of the combined company, with a seven-member board comprising five YOOV and two Avalon designees.

#ALBT Avalon GloboCare and YOOV, a Leading Business AI Automation Solutions Provider, Enter into Merger Agreement

www.stocktitan.net/news/ALBT/avalon-globo-c...

NEWS: ( NASDAQ: #ALBT ) (ALBT) Trading Signals

Revolutionary Cancer Treatment Patent: Avalon's Dual-Target CAR-T Therapy Gets China's Green Light Avalon secures Chinese patent for innovative dual-targeting CAR-T/NK cell therapy, featuring enhanced tumor-specific immune response system for improved cancer treatment

#ALBT Avalon GloboCare Receives Notice of Allowance for Groundbreaking CAR-T and CAR-NK Cell Technology in China

www.stocktitan.net/news/ALBT/avalon-globo-c...

My micro list runners so far today. #stockmarket #Microlist #Daytrading #JFBR #ADD and #ALBT on no news.. yet. In and out of that one. Scary stock with no news.

#ALBT Avalon GloboCare Regains Compliance with Nasdaq Continued Listing Requirements

www.stocktitan.net/news/ALBT/avalon-globo-c...

#ALBT Avalon GloboCare Launches “BrAce for Impact" Affiliate Marketing Program for the KetoAir Breathalyzer Device

www.stocktitan.net/news/ALBT/avalon-globo-c...